ArticleFrontiers in pharmacology2022

Inhibition of HDAC6 With CAY10603 Ameliorates Diabetic Kidney Disease by Suppressing NLRP3 Inflammasome.

Qing Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.